Celia Andreu-Agullo

Director, Biomarkers at Volastra Therapeutics
  • Claim this Profile
Contact Information
Location
New York, New York, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Director, Biomarkers
      • Jun 2022 - Present
    • Principal Scientist (Translational Medicine)
      • Jan 2020 - Jun 2022

      - Provide scientific and strategic support to advance our miRNA-target discovery platform, the foundation of Inspirna's therapies. - Analysis of biomarker data from DNA, RNA and immune cells of clinical samples from Phase 1b/2 clinical trials. - Biomarker discovery and validation. Method development as companion diagnostic (CDx) used in our clinical trials. - Work closely with Clinical Operations team and clinical trial CROs.

    • Senior Scientist
      • Apr 2016 - Jan 2020

      - Responsible for preclinical study design, monitoring, data generation, analysis and interpretation relevant to translational research. - Plan, design and execute pre-clinical IND-enabling pharmacology, toxicology and tumorigenic studies. - Provide scientific and operational management of the translational biology function. - Identify CROs to conduct preclinical studies in the oncology field.

    • United States
    • Hospitals and Health Care
    • Research Associate
      • Feb 2014 - Apr 2016

    • Research Fellow
      • Apr 2009 - Jan 2014

    • PHD Student
      • Jan 2002 - Jun 2008

Community

You need to have a working account to view this content. Click here to join now